Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP
Cabotegravir (Vocabria; ViiV Healthcare) was found to have multiple uses in studies presented at the Conference on Retroviruses and Opportunistic Infections 2025, held in San Francisco, California, from March 9 to March 12, 2025. Cabotegravir was effective as a means […]
Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP Read More »